Medicare utilization — DR. YOUSSEF W. WASSEF (M.D., M.S.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 1,224 | 18 | $0 | $16,137 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 536 | 114 | $0 | $33,821 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 411 | 111 | $0 | $36,810 |
| 80305 | Testing for presence of drug, read by direct observation | 194 | 109 | $0 | $2,350 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 106 | 33 | $0 | $519 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·